Sally Greenberg
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-world outcomes in patients with hormone receptor positive, human epidermal growth factor receptor 2 receptor-negative advanced breast cancer and visceral metastases at baseline - advanced hormone receptor positive breast cancer registry in Australia.
Journal: Internal medicine journal
Published: January 14, 2026
Codesigning the iCanPlan Program to promote advance care planning among consumers from ethnic minority backgrounds in cancer care.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 16, 2025
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: July 18, 2022
Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study.
Journal: Clinical breast cancer
Published: February 26, 2022
Uptake of bone-modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry.
Journal: Internal medicine journal
Published: January 20, 2021
Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid.
Journal: NPJ breast cancer
Published: December 29, 2020
Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: February 29, 2020
Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer.
Journal: Asia-Pacific journal of clinical oncology
Published: December 27, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026